ADVERTISEMENT

Zydus Cadila Gets USFDA Nod for Antibiotic Capsules

Zydus Cadila Gets USFDA Nod for Antibiotic Capsules
New Delhi: Drug firm Zydus Cadila has received approval from the US health regulator to market its generic Doxycycline capsules used for the treatment of bacterial infections in the American market.  "Zydus Cadila has received approval from the United States Food and Drug Administration (USFDA) to market Doxycycline capsules USP, 50 mg, 75 mg, and 100 mg," Cadila Healthcare said in a BSE filing.  The drug falls in the anti-bacteria...
Register for Free
to continue reading
OUR NEWSLETTERS
By signing up you agree to the Terms & Conditions of NDTV Profit